The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Trial to Evaluate the Safety and Efficacy of MB-102 in Patients With BPDCN.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04109482
Recruitment Status : Terminated (Business reasons.)
First Posted : September 30, 2019
Last Update Posted : June 22, 2023
Sponsor:
Information provided by (Responsible Party):
Mustang Bio

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : May 17, 2023
Actual Study Completion Date : May 17, 2023